Horn & Co. represented Nanosynex Ltd. in the deal.Qualigen Therapeutics, Inc. has completed the acquisition of a majority stake in NanoSynex Ltd., an Israeli-based developer of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
